Overexpression of the receptor for resolvin E1 (ERV1) prevents early alveolar bone loss in leptin receptor deficiency‐induced diabetes
- 21 June 2024
- journal article
- research article
- Published by Wiley in Journal of Periodontology
- Vol. 95 (12) , 1190-1200
Abstract
Background: This study was designed to test the hypothesis that the leptin receptor (LepR) regulates changes in periodontal tissues and that the overexpression of the receptor for resolvin E1 (ERV1) prevents age‐ and diabetes‐associated alveolar bone loss.Methods: LepR‐deficient transgenic (TG) mice were cross‐bred with those overexpressing ERV1 (TG) to generate double‐TG mice. In total, 95 mice were divided into four experimental groups: wild type (WT), TG, LepR deficient (db/db), and double transgenic (db/db TG). The groups were followed from 4 weeks up to 16 weeks of age. The natural progression of periodontal disease without any additional method of periodontitis induction was assessed by macroscopic and histomorphometric analyses. Osteoclastic activity was measured by tartrate‐resistant acid phosphatase (TRAP) staining.Results: At 4 weeks, ERV1 overexpression prevented weight gain. From Week 8 onward, there was a significant increase in the weight of db/db mice with or without ERV1 overexpression compared to the WT mice, accompanied by an increase in glucose levels. By 8 weeks of age, the percentage of bone loss in the LepR deficiency groups was significantly greater compared to WT mice. ERV1 overexpression in the db/db TG mice prevented early alveolar bone loss; however, it did not impact the development of diabetic bone loss in aging mice after the onset of weight gain and diabetes.Conclusions: The findings suggest that the overexpression of ERV1 prevents LepR‐associated alveolar bone loss during the early phases of periodontal disease by delaying weight gain, diabetes onset, and associated inflammation; however, LepR deficiency increases susceptibility to naturally occurring inflammatory alveolar bone loss as the animal ages, associated with excess weight gain, onset of diabetes, and excess inflammation.Keywords
This publication has 43 references indexed in Scilit:
- Immunology of Aging: the Birth of InflammagingClinical Reviews in Allergy & Immunology, 2021
- Osteoclast differentiation by RANKL and OPG signaling pathwaysJournal of Bone and Mineral Metabolism, 2020
- Cellular senescence: at the nexus between ageing and diabetesDiabetologia, 2019
- Novel leptin receptor signaling mutants identify location and sex‐dependent modulation of bone density, adiposity, and growthJournal of Cellular Biochemistry, 2018
- Does diabetes increase the risk of periodontitis? A systematic review and meta-regression analysis of longitudinal prospective studiesActa Diabetologica, 2018
- Diabetes, bone and glucose-lowering agents: basic biologyDiabetologia, 2017
- Inflammaging decreases adaptive and innate immune responses in mice and humansBiogerontology, 2015
- Chemerin/chemR23 axis in inflammation onset and resolutionInflammation Research, 2014
- Peripheral leptin regulates bone formationJournal of Bone and Mineral Research, 2012
- Leptin Functions Peripherally to Regulate Differentiation of Mesenchymal Progenitor CellsStem Cells, 2010